159 related articles for article (PubMed ID: 32415090)
1. PRMT1 promotes neuroblastoma cell survival through ATF5.
Hua ZY; Hansen JN; He M; Dai SK; Choi Y; Fulton MD; Lloyd SM; Szemes M; Sen J; Ding HF; Angelastro JM; Fei X; Li HP; Wu CR; Yang SY; Malik K; Bao X; George Zheng Y; Liu CM; Schor NF; Li ZJ; Li XG
Oncogenesis; 2020 May; 9(5):50. PubMed ID: 32415090
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 is an important factor for medulloblastoma cell proliferation and survival.
Gu X; He M; Lebedev T; Lin CH; Hua ZY; Zheng YG; Li ZJ; Yang JY; Li XG
Biochem Biophys Rep; 2022 Dec; 32():101364. PubMed ID: 36237442
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.
Eberhardt A; Hansen JN; Koster J; Lotta LT; Wang S; Livingstone E; Qian K; Valentijn LJ; Zheng YG; Schor NF; Li X
Oncotarget; 2016 Sep; 7(39):63629-63639. PubMed ID: 27571165
[TBL] [Abstract][Full Text] [Related]
4. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
[TBL] [Abstract][Full Text] [Related]
5. Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.
Cho JH; Lee MK; Yoon KW; Lee J; Cho SG; Choi EJ
Cell Death Differ; 2012 May; 19(5):859-70. PubMed ID: 22095282
[TBL] [Abstract][Full Text] [Related]
6. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.
Lee YJ; Chang WW; Chang CP; Liu TY; Chuang CY; Qian K; Zheng YG; Li C
Sci Rep; 2019 Feb; 9(1):1771. PubMed ID: 30741995
[TBL] [Abstract][Full Text] [Related]
8. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
9. Lipotoxicity-Induced PRMT1 Exacerbates Mesangial Cell Apoptosis via Endoplasmic Reticulum Stress.
Park MJ; Han HJ; Kim DI
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671608
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners.
Kim DI; Park MJ; Choi JH; Kim IS; Han HJ; Yoon KC; Park SW; Lee MY; Oh KS; Park SH
Oxid Med Cell Longev; 2015; 2015():617919. PubMed ID: 26583059
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis identifies protein arginine methyltransferases
Wang J; Wu M; Sun J; Chen M; Zhang Z; Yu J; Chen D
Heliyon; 2023 Dec; 9(12):e22088. PubMed ID: 38125466
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
[TBL] [Abstract][Full Text] [Related]
13. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance.
Banerjee D; Boboila S; Okochi S; Angelastro JM; Kadenhe-Chiweshe AV; Lopez G; Califano A; Connolly EP; Greene LA; Yamashiro DJ
Cancer Res Commun; 2023 Dec; 3(12):2518-2530. PubMed ID: 38014922
[TBL] [Abstract][Full Text] [Related]
14. FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.
Akter KA; Mansour MA; Hyodo T; Ito S; Hamaguchi M; Senga T
Tumour Biol; 2016 Apr; 37(4):4531-9. PubMed ID: 26503212
[TBL] [Abstract][Full Text] [Related]
15. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
16. Detection of PRMT1 inhibitors with stopped flow fluorescence.
Qian K; Hu H; Xu H; Zheng YG
Signal Transduct Target Ther; 2018; 3():6. PubMed ID: 29535867
[TBL] [Abstract][Full Text] [Related]
17. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects.
Zhao Z; Zhang J; Ren Y; Dong L; Wu H; Hong W; Huang H; Yang X; Pang Z; Wang H
Bioorg Med Chem; 2023 Sep; 92():117436. PubMed ID: 37556911
[TBL] [Abstract][Full Text] [Related]
20. PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes.
Jeong MH; Jeong HJ; Ahn BY; Pyun JH; Kwon I; Cho H; Kang JS
Cell Death Dis; 2019 Dec; 10(12):903. PubMed ID: 31787756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
